Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gulf Regional Research & Educational Services (GRRES) is a clinical research organization and site based in Metairie, Louisiana, specializing in cardiovascular and metabolic health. Led by Dr. Thomas D. Giles, the organization conducts Phase 4 clinical trials and mechanistic studies focusing on hypertension, arterial stiffness, and Type 2 diabetes. GRRES has notably investigated the physiological effects of SGLT2 inhibitors like dapagliflozin and beta-blockers like nebivolol on blood pressure regulation and endothelial function. The entity frequently collaborates with academic institutions such as the Tulane University School of Medicine to advance clinical understanding of cardiovascular risk factors. Through its research, GRRES provides critical data on the mechanistic pathways of established therapies in real-world patient populations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gulf Regional Research & Educational Services.